CUV 1.61% $14.68 clinuvel pharmaceuticals limited

OTC Novel product range, page-5

  1. 14 Posts.
    lightbulb Created with Sketch. 4
    The primary endpoint for CUV156 is listed as October. The yearly report a few weeks ago said they are doing analysis and finishing treatment for some patients. So that means at least several weeks from then. So basically anytime between now and end of October I would expect a readout.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.